PDYN Fundamental Analysis - PALLADYNE AI CORP

Name: PALLADYNE AI CORP (PDYN) Stock
Brand: PALLADYNE AI CORP
Rating: 5 (3 reviews)

Fundamental Rating

Taking everything into account, PDYN scores 3 out of 10 in our fundamental rating. PDYN was compared to 130 industry peers in the Machinery industry. No worries on liquidiy or solvency for PDYN as it has an excellent financial health rating, but there are worries on the profitability. PDYN is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year PDYN has reported negative net income.

In the past year PDYN has reported a negative cash flow from operations.

1.2 Ratios

With a Return On Assets value of -57.20%, PDYN is not doing good in the industry: 90.00% of the companies in the same industry are doing better.

With a Return On Equity value of -83.21%, PDYN is not doing good in the industry: 85.38% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-57.2%
ROE	-83.21%
ROIC	N/A

ROA(3y)-138.04%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PDYN has a better Gross Margin (57.31%) than 96.15% of its industry peers.

PDYN's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for PDYN so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	57.31%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y32.37%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PDYN does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for PDYN has been increased compared to 1 year ago.

PDYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -0.11, we must say that PDYN is in the distress zone and has some risk of bankruptcy.

PDYN's Altman-Z score of -0.11 is on the low side compared to the rest of the industry. PDYN is outperformed by 82.31% of its industry peers.

PDYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-0.11

ROIC/WACCN/A

WACC9.56%

2.3 Liquidity

A Current Ratio of 17.12 indicates that PDYN has no problem at all paying its short term obligations.

With an excellent Current ratio value of 17.12, PDYN belongs to the best of the industry, outperforming 98.46% of the companies in the same industry.

PDYN has a Quick Ratio of 17.10. This indicates that PDYN is financially healthy and has no problem in meeting its short term obligations.

With an excellent Quick ratio value of 17.10, PDYN belongs to the best of the industry, outperforming 98.46% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	17.12
Quick Ratio	17.1

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PDYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.35%, which is quite impressive.

Looking at the last year, PDYN shows a very negative growth in Revenue. The Revenue has decreased by -50.07% in the last year.

PDYN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.33% yearly.

EPS 1Y (TTM)42.35%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0.75%

Revenue 1Y (TTM)-50.07%

Revenue growth 3Y15.33%

Revenue growth 5YN/A

Sales Q2Q%-62.59%

3.2 Future

PDYN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.66% yearly.

Based on estimates for the next years, PDYN will show a very strong growth in Revenue. The Revenue will grow by 44.11% on average per year.

EPS Next Y95.05%

EPS Next 2Y12.13%

EPS Next 3Y16.82%

EPS Next 5Y15.66%

Revenue Next Year-38.04%

Revenue Next 2Y-5.46%

Revenue Next 3Y42.96%

Revenue Next 5Y44.11%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PDYN. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PDYN. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PDYN's earnings are expected to grow with 16.82% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y12.13%

EPS Next 3Y16.82%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for PDYN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PALLADYNE AI CORP

NASDAQ:PDYN (11/3/2025, 5:27:14 PM)

After market: 7.81 +0.06 (+0.77%)

7.75

-0.62 (-7.41%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)08-05 2025-08-05

Earnings (Next)11-11 2025-11-11

Inst Owners18.19%

Inst Owner ChangeN/A

Ins Owners23.12%

Ins Owner Change29.65%

Market Cap325.11M

Revenue(TTM)4.36M

Net Income(TTM)-44793000

Analysts80

Price Target15.3 (97.42%)

Short Float %19.4%

Short Ratio2.92

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)8.13%

Min Revenue beat(2)-23.45%

Max Revenue beat(2)39.71%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)-5.26%

EPS NQ rev (3m)-5.26%

EPS NY rev (1m)93.51%

EPS NY rev (3m)93.51%

Revenue NQ rev (1m)-24.26%

Revenue NQ rev (3m)-24.26%

Revenue NY rev (1m)-17.09%

Revenue NY rev (3m)-17.09%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	74.62
P/FCF	N/A
P/OCF	N/A
P/B	6.04
P/tB	6.04
EV/EBITDA	N/A

EPS(TTM)-1.74

EYN/A

EPS(NY)-0.76

Fwd EYN/A

FCF(TTM)-0.54

FCFYN/A

OCF(TTM)-0.53

OCFYN/A

SpS0.1

BVpS1.28

TBVpS1.28

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-57.2%
ROE	-83.21%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	57.31%
FCFM	N/A

ROA(3y)-138.04%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y32.37%

GM growth 5YN/A

F-Score5

Asset Turnover0.06

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	17.83%
Cap/Sales	3.51%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	17.12
Quick Ratio	17.1
Altman-Z	-0.11

F-Score5

WACC9.56%

ROIC/WACCN/A

Cap/Depr(3y)30.56%

Cap/Depr(5y)N/A

Cap/Sales(3y)8.8%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)42.35%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0.75%

EPS Next Y95.05%

EPS Next 2Y12.13%

EPS Next 3Y16.82%

EPS Next 5Y15.66%

Revenue 1Y (TTM)-50.07%

Revenue growth 3Y15.33%

Revenue growth 5YN/A

Sales Q2Q%-62.59%

Revenue Next Year-38.04%

Revenue Next 2Y-5.46%

Revenue Next 3Y42.96%

Revenue Next 5Y44.11%

EBIT growth 1Y39.74%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year13.54%

EBIT Next 3Y11.18%

EBIT Next 5Y15.99%

FCF growth 1Y70.42%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y70.47%

OCF growth 3YN/A

OCF growth 5YN/A

PALLADYNE AI CORP / PDYN FAQ

What is the ChartMill fundamental rating of PALLADYNE AI CORP (PDYN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PDYN.

What is the valuation status of PALLADYNE AI CORP (PDYN) stock?

ChartMill assigns a valuation rating of 0 / 10 to PALLADYNE AI CORP (PDYN). This can be considered as Overvalued.

Can you provide the profitability details for PALLADYNE AI CORP?

PALLADYNE AI CORP (PDYN) has a profitability rating of 1 / 10.

What is the expected EPS growth for PALLADYNE AI CORP (PDYN) stock?

The Earnings per Share (EPS) of PALLADYNE AI CORP (PDYN) is expected to grow by 95.05% in the next year.

PALLADYNE AI CORP (PDYN) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PALLADYNE AI CORP / PDYN FAQ

What is the ChartMill fundamental rating of PALLADYNE AI CORP (PDYN) stock?

What is the valuation status of PALLADYNE AI CORP (PDYN) stock?

Can you provide the profitability details for PALLADYNE AI CORP?

What is the expected EPS growth for PALLADYNE AI CORP (PDYN) stock?